The free contraception scheme was launched in September 2022, initially for those aged 17-25. It has been gradually expanded and now includes women aged 17-35 from July 1st, 2024. Approximately 2,400 GPs and 2,050 pharmacies have signed up to provide services and products under the scheme to date. The scheme is open to women, girls and other people identifying as transgender or non-binary, who are ordinarily resident in Ireland and for whom prescription contraception is deemed suitable by their doctors.
The scheme covers the cost of consultations with GPs, primary care, student health and family planning centres and prescriptions for the wide range of contraceptive options available on the HSE Re-Imbursement List, including long-acting reversible contraception (LARCs: injections, intra-uterine devices and systems (coils) and implants) and emergency contraception in addition to the contraceptive Pill, patch and ring. LARC fittings, removals, injections and check-ups are also free of charge under the scheme.
Women who have had coils, IUDs, IUSs or implants inserted while eligible under the scheme remain eligible for subsequent checks and free removal of any devices inserted prior to reaching the eligibility limit (currently their 36th birthday), to ensure continuity of care.
The FCS has been set up primarily as a primary care led service; the removal of coils and implants is included in the range of services that are free of charge to patients accessing the FCS through participating medical facilities, including GP services, family planning, student health and primary care centres. As not all GPs have completed training for insertion, checking and removal of contraceptive devices, the scheme contains the facility for GPs to refer to other GPs, primary care, family planning and acute services with the appropriate expertise.
In the minority of cases where ultrasound is needed to locate long acting reversible contraceptive devices prior to removal, many GPs and family planning centres do not have direct access to ultrasound on their own premises. Under these circumstances, patients may be referred to a specialist centre to have the device removed with the help of an ultrasound scan. Whether or not charges apply may depend on the nature of the specialist centre to which the patient is referred (i.e., whether or not the centre in question is participating in the scheme, and whether it is public or private).
Within the public system, some funding has been provided to the National Women and Infants Health Programme (NWIHP) to provide free contraception to eligible women accessing SATUs, maternity and gynaecology services, where they are unable for a variety of reasons to access the service they need through primary care.
For more information on the frequency of need for ultrasound on removal of LARCs and availability of ultrasound to aid complex LARC removals through public services, as this is a service matter, I have asked the HSE to respond directly to the Deputy as soon as possible.